Sino-European Joint Biopharmaceutical Laboratory Settles Into Shijiazhuang
This article was originally published in PharmAsia News
Executive Summary
Irish biopharmaceutical company Bimeda recently signed an agreement with Shijiazhuang Science and Technology Center to establish a joint laboratory, which will serve as the city's international biopharmaceutical technological services platform